MRI

Latest News


CME Content


MRI is the best method to assess breast cancer tumor size prior to surgery and after chemotherapy, according to findings from the American College of Radiology Imaging Network trial 6657. Size on mammography does not correlate with true residual disease in patients treated with neoadjuvant chemotherapy and thus MRI is the best modality, the researchers said.

CMC-001, an investigational MRI liver contrast medium, may be at least a partial answer to reducing the long imaging times that have frustrated patients and encouraged radiologists to look for imaging alternatives to aid diagnosis of hepatocellular carcinoma and colon cancer metastases in the liver. A phase III trial indicates it is as sensitive as a gadolinium-enhanced MRI for detecting colon cancer metastases, but at the cost of lower specificity.

Siemens brought two blockbuster MR offerings to the RSNA meeting this week: the 3T Skyra and 1.5T Aera. The two new products, works-in-progress pending FDA clearance but scheduled to begin shipping by mid-2010, promise a productivity lift through their patient-friendly bores, measuring 70 cm wide, and automation that simplifies complex scan tasks.

Siemens unveiled a new information technology at RSNA 2009: software that promises to do the tedious and time-consuming tasks involved in reading MR and CT exams. The new product, a work-in-progress pending FDA clearance, is an outgrowth of the syngo platform that Siemens has used for years to provide consistency in data processing among its modalities.

Using 3T MR imaging, California researchers have found that high levels of physical activity may be linked to knee abnormalities in middle-aged men and women. People between the ages of 45 and 55 who engage in several hours of walking, sports, or other types of exercise per week may be at greater risk of developing osteoarthritis than less active adults, according to a study presented Monday at the 2009 RSNA meeting.

CMS will increase the equipment utilization rate assumption used to determine the practice expense for all nontherapeutic medical equipment, including diagnostic imaging systems, from 50% to 90% under new Medicare fee schedule rules announced Friday. In a bit of good news for radiology, CMS said it remains on track to require that suppliers of advanced imaging services become accredited by 2012.